Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial.
Henrique Rodrigues Scherer CoelhoSilvia Cordeiro das NevesJovino Nogueira da Silva MenezesAndréia Conceição Milan Brochado Antoniolli-SilvaRodrigo Juliano OliveiraPublished in: Stem cell research & therapy (2023)
The results indicate that stem cell therapy led to improvements in voiding function. Cell therapy with adipose tissue-derived stem cells is safe and should be considered a new therapeutic option for the treatment of detrusor underactivity. Trial registration ISRCTN, ISRCTN23909398; Registered 15 March 2021-Retrospectively registered, https://doi.org/10.1186/ISRCTN23909398.